Hellenic Institute For The Study Of Sepsis

This study is testing whether a drug called emapalumab can help patients with severe sepsis who have a specific overactive immune response. It involves 75 adults in Greece with sepsis from infections like pneumonia, comparing two doses of the drug against a placebo. The main goal…

This study is testing a new strategy to manage severe infections like sepsis. It uses rapid tests to identify the specific germ causing the infection and its antibiotic resistance much faster than standard methods. The goal is to help doctors prescribe the most effective antibiot…